These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12412736)
1. Idiopathic myelofibrosis with prominent postsplenectomy erythroblastosis terminating in acute myeloid transformation. Tóth P; Tóth Z Haematologia (Budap); 2002; 32(2):155-61. PubMed ID: 12412736 [TBL] [Abstract][Full Text] [Related]
2. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Mesa RA; Elliott MA; Tefferi A Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148 [TBL] [Abstract][Full Text] [Related]
3. Polycythemia vera terminating in acute myelogenous leukemia with fibrosis of bone marrow: case report. Hoshino T; Kawasaki S; Okada H; Yamamoto T; Kimura K Nihon Ketsueki Gakkai Zasshi; 1967 Apr; 30(2):214-27. PubMed ID: 5234877 [No Abstract] [Full Text] [Related]
4. Idiopathic myelofibrosis developing isolated granulocytic sarcoma with der (1;7)(q10; p10) after splenectomy and finally transforming to acute myelogenous leukemia. Kasahara S; Tsurumi H; Hara T; Goto H; Moriwaki H Leuk Lymphoma; 2000 Oct; 39(3-4):427-33. PubMed ID: 11342325 [TBL] [Abstract][Full Text] [Related]
5. [Myeloid leukemia with myelofibrosis (author's transl)]. Duhamel G; Gorin NC; Najaman A; André R Nouv Rev Fr Hematol; 1975; 15(1):99-105. PubMed ID: 126427 [TBL] [Abstract][Full Text] [Related]
6. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders. Hasselbalch H; Clemmensen I Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850 [TBL] [Abstract][Full Text] [Related]
7. Palliative splenectomy in myelofibrosis with myeloid metaplasia. Mesa RA; Tefferi A Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645 [TBL] [Abstract][Full Text] [Related]
8. Idiopathic acquired sideroblastic anemia terminating in acute myelofibrosis: case report and review of leterature. Yeung K; Trowbridge AA Cancer; 1977 Jan; 39(1):359-65. PubMed ID: 318917 [TBL] [Abstract][Full Text] [Related]
9. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)]. Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391 [TBL] [Abstract][Full Text] [Related]
10. Essential thrombocythemia terminating in myelofibrosis and myeloblastic transformation. Yonemitsu H; Okuda K Jpn J Med; 1985 Feb; 24(1):57-61. PubMed ID: 3858568 [TBL] [Abstract][Full Text] [Related]
11. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases. Tinggaard Pedersen N; Laursen B Scand J Haematol; 1983 Jan; 30(1):50-8. PubMed ID: 6573016 [TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases. Akpek G; McAneny D; Weintraub L J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482 [TBL] [Abstract][Full Text] [Related]
13. [Metamorphosis of chronic myeloproliferative diseases]. Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716 [No Abstract] [Full Text] [Related]
14. [Splenectomy in 5 patients with idiopathic myelofibrosis]. Nozato A; Mizorogi F; Fukumi S; Watanabe H; Kobayashi M Rinsho Ketsueki; 2001 Aug; 42(8):627-32. PubMed ID: 11579502 [TBL] [Abstract][Full Text] [Related]
15. Primary myelofibrosis terminating in megakaryoblastic crisis. Kurashima K; Kawamura Y; Ohka T; Hayashi M; Matsuda T Jpn J Med; 1990; 29(2):226-9. PubMed ID: 2232372 [TBL] [Abstract][Full Text] [Related]
16. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report. Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167 [TBL] [Abstract][Full Text] [Related]
17. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias". Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781 [TBL] [Abstract][Full Text] [Related]
18. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders. Eid J; Ebert RF; Gesell MS; Spivak JL Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis. Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679 [TBL] [Abstract][Full Text] [Related]
20. Idiopathic myelofibrosis with unusually high erythroblastosis in the peripheral blood. Osman Y; Kishi K; Narita M; Saito H; Masuko M; Koike T; Shibata A Am J Hematol; 1996 Jun; 52(2):122-3. PubMed ID: 8638637 [No Abstract] [Full Text] [Related] [Next] [New Search]